Absolute MI risk a basis for treatment decisions in diabetes

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1242, 2000-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimising treatment after acute MI in patients with diabetes

Inpharma, Vol. 1, Iss. 1272, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Diabetes Care: Risk Factors, Prediction, Prevention, and Individualized Treatment

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 8, Iss. 2, 2008-06 ,pp. : 68-69

Bentham Science Publishers

Access to resources Recommend Favorite

Abacavir not associated with MI risk

Reactions Weekly, Vol. 1, Iss. 1345, 2011-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Abacavir: inconsistent results for MI risk

Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Abacavir: inconsistent results for MI risk

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite